SAM #W911SR-24-R-CWMD

Army Seeks 501(c)(3) Partner for VEDDER Prototype Accelerator in Biotech & AI

This opportunity seeks a 501(c)(3) non-profit partner to establish and operate the VEDDER Prototype Accelerator for the Department of Defense, Army Contracting Command - Aberdeen Proving Ground. - Government Buyer: - Department of Defense, Department of the Army, Army Contracting Command - Aberdeen Proving Ground (ACC-APG) - Portfolio Acquisition Executive-Layered Protection & Integration (PAE-LPI) - OEMs and Vendors: - No specific OEMs or commercial vendors are named; focus is on biotechnology, AI, and HPC innovators - Lawrence Livermore National Laboratory (LLNL) referenced as a key government HPC resource - Products/Services Requested: - Establishment and operation of a technology accelerator for rapid prototyping of medical countermeasures (MCMs) and emerging defense/detection technologies - Technology scouting and market vetting for dual-use innovations - B2B prototyping agreements and system integration - Secure, cloud-based program management platform (IL5 compliant) - High-performance computing integration (LLNL or equivalent) - Secure software development and network authorization (SSDF, RMF, STIG compliance) - Foreign influence and risk-based security vetting - Real-time oversight and milestone-based funding tied to KPIs - Unique/Notable Requirements: - Must be a 501(c)(3) non-profit organization - Accelerator model inspired by venture-backed intelligence community approaches - Up to three partners may be selected for distinct missions - Strict cybersecurity and risk management for all software and network operations - Integration of private sector, academic, and government resources - Place of Performance and Delivery: - Aberdeen Proving Ground, Maryland (Army contracting office and place of performance) - Lawrence Livermore National Laboratory (HPC integration) - U.S. Army federal office (government facility)

Description

The United States and the Portfolio Acquisition Executive-Layered Protection &Integration (PAE-LPI) is engaged in a critical, persistent innovation race against strategic competitors, most notably the People's Republic of China (PRC), which leverages Military-Civil Fusion to mandate the immediate transfer of commercial breakthroughs to military applications. Traditional Department of War (DoW) acquisition models operating on 7-to-15-year timelines are structurally incapable of pacing the threat in rapidly evolving domains like biotechnology and artificial intelligence (AI).

To maintain technological overmatch and secure the United States’ biotechnology ecosystem (projected to exceed $1.5 trillion), the Government requires an asymmetric response that harnesses the dynamic, free-market ecosystem of private capital, academia, and commercial enterprise. Drawing inspiration from venture-backed intelligence community models, this Other Transaction Agreement (OTA) establishes a public-private nexus.

The objective of this OTA is to establish a technology accelerator with a 501(c)(3) partner. Supported by Government investment, this accelerator will speed the prototyping of new technologies; specifically medical countermeasures (MCMs), by bridging the private sector, elite national High-Performance Computing (HPC) resources, and the Government.

View original listing